About Vanthys Pharmaceutical Development Private Limited
Data last updated:
Vanthys Pharmaceutical Development Private Limited was a private limited company based in Noida, Uttar Pradesh, India, operated as a subsidiary of Jubilant Innovation Pte. Limited. The company has been dissolved (liquidated) as per MCA records and no longer exists as a legal entity. Any dealings with a dissolved entity carry legal and financial risk. It operated in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 11 May 2009.
The company was registered with the Registrar of Companies (ROC), Kanpur, under CIN U73100UP2009PTC037333. The company has 1 GST registration on record, which is no longer active.
The company had an authorised share capital of ₹22.5 Cr and a paid-up capital of ₹22.5 Cr. It was led by directors including Benny Thomas and Shyamsundar Bang.
Its last annual general meeting (AGM) was held on 20 September 2018, and its latest financial statements are for the year ended 31 March 2018. The registered office was at 1A Sector 16A Institutional Area, Noida, Uttar Pradesh, India – 201301.
As per the financials filed for FY 2018, the company reported a revenue of ₹29.46 Lakh. For the same year it recorded a net profit of ₹20.55 Lakh (net margin 69.8%) and EBITDA of ₹27.56 Lakh (EBITDA margin 93.6%). Revenue has grown at a compounded annual rate (CAGR) of 1% over three years.
The company was associated with 4 brands: Jubilant Biosys, Jubilant Pharma, Jubilant Pharmova and Jubilant Life Sciences. The company has 1 deal on record (1 acquisition); the latest was in January 2012.
The last known website on record is jubilantpharmova.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered Address1A Sector 16A Institutional Area, Noida, Uttar Pradesh, India – 201301
- IndustryPharma, Pharma Contract R&D
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Vanthys Pharmaceutical Development Private Limited FY 2018 filings available
Vanthys Pharmaceutical Development Private Limited reported revenue of ₹29.46 Lakh for FY 2018.
Compounded Annual Growth Rate (CAGR) of Vanthys Pharmaceutical Development Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 1% over three years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Vanthys Pharmaceutical Development Private Limited
| Metrics | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• |
| Total Revenue | ₹29.46 Lakh | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• |
| EBITDA | ₹27.56 Lakh | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹20.55 Lakh | •••• | •••• | •••• |
| Balance Sheet | ||||
| Share Capital | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• |
Financial Ratios of Vanthys Pharmaceutical Development Private Limited
| Metrics | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 93.6% | •••• | •••• | •••• |
| Net Profit Margin | 69.8% | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• |
| Liquidity and Debt | ||||
| Current Ratio | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• |
| Efficiency and Growth | ||||
| Asset Turnover | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Vanthys Pharmaceutical Development are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Auditor Details of Vanthys Pharmaceutical Development Private Limited
Vanthys Pharmaceutical Development Private Limited is audited by B S R & Co. LLP for the financial year 2018.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| B S R & Co. LLP | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors and KMP of Vanthys Pharmaceutical Development Private Limited
Vanthys Pharmaceutical Development Private Limited currently reports 3 directors and 1 key managerial person. 18 former directors have served the organization.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Benny Thomas Also directs: Sami Nutraceuticals Private Limited | Director | 28 Mar 2018 | 8 Years 6 Months | As last reported |
| Saravanakumar Dhakshinamoorthy | Additional Director | 15 May 2019 | 7 Years 4 Months | As last reported |
| Shwetank Tiwari Also directs: Sumant Investments Pvt.Ltd. | Company Secretary | 16 Jan 2018 | 8 Years 8 Months | As last reported |
| Shyamsundar Bang | Director | 28 Mar 2018 | 8 Years 6 Months | As last reported |
Ownership and Shareholding of Vanthys Pharmaceutical Development Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Vanthys Pharmaceutical Development Private Limited
Vanthys Pharmaceutical Development Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Deals & Funding of Vanthys Pharmaceutical Development Private Limited
Vanthys Pharmaceutical Development Private Limited has 1 deal on record (1 acquisition); the latest was in January 2012.
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jan 2012 | Acquisition | Undisclosed | Buyer: Jubilant Pharmova Limited Seller: Eli Lilly and Co. |
Full deal history
All 1 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Associated Brands with Vanthys Pharmaceutical Development Private Limited
Vanthys Pharmaceutical Development operates multiple associated brands including Jubilant Biosys, Jubilant Pharma, and Jubilant Pharmova. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Offers integrated drug discovery, research, and manufacturing for pharmaceuticals. | jubilantbiosys.com | |
| Pharmaceuticals, APIs, and radiopharmaceuticals are manufactured by the company. | jubilantpharma.com | |
| CDMO focused on manufacturing of solid, semi solid, liquid, and injectible drug formulations | jubilantpharmova.com | |
| Company offering a suite of R&D and manufacturing services for small molecules and generics | jubl.com |
Employees and EPFO Compliance at Vanthys Pharmaceutical Development Private Limited
Employment history and EPFO contributions of people linked to Vanthys Pharmaceutical Development.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
News related to Vanthys Pharmaceutical Development Private Limited
Recent Activity on Vanthys Pharmaceutical Development Private Limited
Vanthys Pharmaceutical Development Private Limited has 20 board changes on record since 2011: 4 appointments and 16 cessations. The latest: Shyamsundar Bang ceased to be Director on 03 Feb 2021.
11 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Vanthys Pharmaceutical Development Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Vanthys Pharmaceutical Development Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Vanthys Pharmaceutical Development Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Vanthys Pharmaceutical Development Private Limited
Vanthys Pharmaceutical Development has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Vanthys Pharmaceutical Development Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vanthys Pharmaceutical Development Private Limited
Vanthys Pharmaceutical Development has been "Dissolved (Liquidated)" as per MCA records. The company has ceased to exist as a legal entity. Any contracts or dealings with a dissolved entity may be legally unenforceable.
Vanthys Pharmaceutical Development was a private limited company based in Noida, Uttar Pradesh, India. The company worked in pharma contract r and d, within the pharma industry. It was incorporated on 11 May 2009 and is registered under CIN U73100UP2009PTC037333. The company is recorded as dissolved (liquidated) in MCA records and no longer exists as a legal entity.
Vanthys Pharmaceutical Development was incorporated on 11 May 2009. It is registered with the Registrar of Companies, Kanpur.
Vanthys Pharmaceutical Development had 4 directors and KMP:
- Benny Thomas - Director
- Saravanakumar Dhakshinamoorthy - Additional Director
- Shyamsundar Bang - Director
- Shwetank Tiwari - Company Secretary
The CIN (Corporate Identification Number) of Vanthys Pharmaceutical Development is U73100UP2009PTC037333. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Vanthys Pharmaceutical Development is at 1A Sector 16A Institutional Area, Noida, Uttar Pradesh, India – 201301.
Vanthys Pharmaceutical Development can be reached through the website jubilantpharmova.com. Its registered office is in Noida, Uttar Pradesh, India.
Vanthys Pharmaceutical Development reported revenue of ₹29.46 Lakh for FY 2018.
Vanthys Pharmaceutical Development has an authorised share capital of ₹22.5 Cr and a paid-up capital of ₹22.5 Cr.
Vanthys Pharmaceutical Development reported a net profit of ₹20.55 Lakh (net margin 69.8%) and EBITDA of ₹27.56 Lakh (EBITDA margin 93.6%) for FY 2018, as per its filed financial statements.